Apogee Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Apogee Therapeutics's balance sheet done over the years? Its assets were worth $401,404,000 last year, which is more than in the previous period. 5% of Apogee Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $21,491,000, which means an increase by 115% compared compared to last year.

Debt to Assets

Apogee Therapeutics, Inc. (NASDAQ:APGE): Debt to assets
2022 152055000 9.98M 6.56%
2023 401404000 21.49M 5.35%

APGE Balance Sheet (2022 – 2023)

2023 2022
Assets
Current assets:
Cash and cash equivalents
118.31M151.89M
Short term investments
277.14M0
Net receivables
00
Inventory
00
Other current assets
2.95M57K
Total current assets
398.40M152.05M
Non-current assets:
Property, Plant and Equipment
2.59M0
Goodwill
00
Intangible assets
00
Long term investments
00
Other non-current assets
401K0
Total non-current assets
2.99M0
Total assets
401.40M152.05M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00
Short term debt
2.20M0
Total current liabilities
20.55M9.98M
Non-current liabilities:
Long term debt
933K0
Deferred tax
00
Other non-current liabilities
00
Total non-current liabilities
933K0
Total liabilities
21.49M9.98M
Data source